![sno-bio_500](https://jumpstart.vc/wp-content/uploads/2022/02/sno-bio_500.jpg)
Company Description
SNO Bio is an early-stage biopharmaceutical company developing novel therapeutics targeting enzymes associated with S-nitrosylation, a post-translational protein modification operating as a fundamental biological mechanism controlling cell signaling.
Industry Sector
Biomedical & Health Tech
Founded
2020
JumpStart Investment
Evergreen Fund